Animal experiments have demonstrated that myocardial cells expressing the specific CaMKII inhibitory peptide AC3-I, the same amino acid sequence as that in the present study, can weaken cardiac remodeling and the degree of heart failure. This evidence concerns the gene CAMK2G and heart failure.